keyword
https://read.qxmd.com/read/37926586/effects-of-trazodone-and-dexmedetomidine-on-fentanyl-mediated-reduction-of-isoflurane-minimum-alveolar-concentration-in-cats
#21
JOURNAL ARTICLE
Robert J Brosnan, Bruno H Pypendop, Alessia Cenani
OBJECTIVE: To screen modulators of biogenic amine (BA) neurotransmission for the ability to cause fentanyl to decrease isoflurane minimum alveolar concentration (MAC) in cats, and to test whether fentanyl plus a combination of modulators decreases isoflurane MAC more than fentanyl alone. STUDY DESIGN: Prospective, experimental study. ANIMALS: A total of six adult male Domestic Short Hair cats. METHODS: Each cat was anesthetized in three phases with a 1 week washout between studies...
October 7, 2023: Veterinary Anaesthesia and Analgesia
https://read.qxmd.com/read/37900518/a-comprehensive-review-of-the-generalized-anxiety-disorder
#22
REVIEW
Aneesh K Mishra, Anuj R Varma
Excessive, uncontrollable, and usually unjustified worry about certain things is a sign of the mental and behavioral disease known as generalized anxiety disorder (GAD). Genetic research suggests that numerous genes are likely implicated in the development of GAD, even if much is yet unclear about this. As a result, if someone in a family has GAD, there is a high likelihood that someone else will also suffer from the illness, as well as another anxiety disorder. Individuals with GAD are frequently overly bothered about workaday affairs like health, assets, demise, family, accord issues, or effort challenges...
September 2023: Curēus
https://read.qxmd.com/read/37795037/functional-consequences-of-a-rare-human-serotonergic-5-ht-1a-receptor-variant
#23
JOURNAL ARTICLE
Merav Tauber, Yair Ben-Chaim
Serotonin (5-HT) plays a central role in various brain functions via the activation of a family of receptors, most of them G protein coupled receptors (GPCRs). 5-HT1A receptor, the most abundant 5-HT receptors, was implicated in many brain dysfunctions and is a major target for drug discovery. Several genetic polymorphisms within the 5-HT1A receptor gene were identified and linked to different conditions, including anxiety and depression. Here, we used Xenopus oocytes to examine the effects of one of the functional polymorphism, Arg220Leu, on the function of the receptor...
2023: Frontiers in Pharmacology
https://read.qxmd.com/read/37793485/anxiolytic-like-action-of-3-4-methoxyphenyl-selanyl-2-phenylbenzofuran-sebzf3-in-mice-a-possible-contribution-of-the-serotonergic-system
#24
JOURNAL ARTICLE
Larissa Sander Magalhães, Dianer Nornberg Strelow, Mariana Parron Paim, Taís da Silva Teixeira Rech, Letícia Devantier Krüger, Antonio Luiz Braga, José Sebastião Santos Neto, César Augusto Brüning, Cristiani Folharini Bortolatto
Anxiety disorders, characterized by high prevalence rates, cause psychiatric disabilities and are related to impairments in serotoninergic system function. Frequent anxiety recurrence, resistance, and drug adverse effects have driven searches for new therapies. We initially evaluated the anxiolytic-like activity of 3-selanyl-benzo[b]furan compounds (SeBZF1-5) (50 mg/kg, i.g.) in male Swiss mice using the light-dark test (LDT). The compound 3-((4-methoxyphenyl)selanyl)-2-phenylbenzofuran (SeBZF3) exhibited anxiolytic-like activity...
October 2, 2023: Pharmacology, Biochemistry, and Behavior
https://read.qxmd.com/read/37764844/a-high-performance-liquid-chromatography-with-photodiode-array-detection-method-for-simultaneous-determination-of-three-compounds-isolated-from-wikstroemia-ganpi-assessment-of-the-effects-on-cytochrome-p450-mediated-metabolism-in-vitro-and-in-vivo
#25
JOURNAL ARTICLE
Min-Ji Keem, Seong-Wook Seo, Taeyoung Kim, Beom-Geun Jo, Su-Nam Kim, In-Soo Yoon, Min Hye Yang
In natural products, the content and quality of the marker components differ depending on the part, production area, collection period, and extraction method; therefore, a standardized analysis method is required to obtain consistent results. This study developed a simultaneous analysis method for three marker components (7-methoxylutolin-5- O -glucoseide, pilloin 5- O -β-d-glucopyranoside, rutarensin) isolated and purified from Wikstroemia ganpi ( W. ganpi ). Simultaneous analysis was performed using high-performance liquid chromatography with photodiode array detection (HPLC-PDA) method that was validated according to the International Council for Harmonisation (ICH) guidelines...
September 19, 2023: Nutrients
https://read.qxmd.com/read/37732133/augmentation-therapy-with-serotonin-1a-receptor-partial-agonists-on-neurocognitive-function-in-schizophrenia-a-systematic-review-and-meta-analysis
#26
JOURNAL ARTICLE
Risa Yamada, Ayumu Wada, Andrew Stickley, Yuma Yokoi, Tomiki Sumiyoshi
BACKGROUND: In a previous meta-analysis, the use of serotonin1A (5-HT1A ) receptor partial agonists of the azapirone class as an add-on therapy was associated with beneficial effects on positive symptoms and attention/processing speed in schizophrenia patients. This meta-analysis builds on that study by examining the effects of adjunctive treatment with 5-HT1A partial agonists in improving other domains of neurocognitive function in schizophrenia patients. METHODS: A literature search was performed from 1987 to May 2023 to identify randomized controlled trials...
December 2023: Schizophrenia Research. Cognition
https://read.qxmd.com/read/37714122/-autism-pharmacological-treatment
#27
REVIEW
Víctor Ruggieri
Autism is a neurodevelopmental disorder characterized by deficits in social cognition and communication, restricted interests, and stereotyped behaviors. Frequently associated with sensory dysfunction, other neurodevelopmental disorders, neuropsychiatric disorders, epilepsy and/or sleep disorders. This condition will accompany people throughout their lives, which will generate various support and treatment needs. Although there are no drugs that modify the core symptoms of autism, various drugs have shown their usefulness in associated conditions...
September 2023: Medicina
https://read.qxmd.com/read/37668149/methodological-approach-using-a-within-subjects-design-in-the-marble-burying-assay
#28
JOURNAL ARTICLE
Kaitlyn J Partridge, Ruth Olson, Todd M Hillhouse
In 2016, the National Institutes of Health mandated the use of both male and female mice in funded research. The use of both sexes is an important variable to consider; however, it comes with negative consequences such as increased animal expenses. One way to combat these negatives is to explore the option of using a within-subjects design (repeated measures) in behavioral assays that historically use a between-subjects design. Our study aimed to determine if a within-subjects design can be utilized in the marble burying assay...
September 1, 2023: Behavioural Pharmacology
https://read.qxmd.com/read/37664331/serotonin-syndrome-precipitated-by-paxlovid-initiation
#29
Nicholas G Nasser, Connor Welsh, Avir Mitra, Matthew Swan
A female in her early 40s taking buspirone, quetiapine, and daily kratom presented to the emergency department two days after starting a course of Paxlovid for a mild COVID-19 infection with diffuse tremors, ocular clonus, diaphoresis, and confusion consistent with serotonin syndrome (SS). The patient was treated with oral lorazepam, and her symptoms significantly improved within one hour without the need for additional dosing. To our knowledge, this is the first reported case of SS in a COVID-19-positive patient who was prescribed Paxlovid...
August 2023: Curēus
https://read.qxmd.com/read/37662371/serotonin-therapies-for-opioid-induced-dysphagia-and-respiratory-depression-sex-differences-in-a-rat-electromyography-model
#30
Michael Frazure, In Morimoto, Nathan Fielder, Nicholas Mellen, Kimberly Iceman, Teresa Pitts
Opioids are well-known to cause respiratory depression, but despite clinical evidence of dysphagia, the effects of opioids on swallow excitability and motor pattern are unknown. We sought to test the effects of the clinically-relevant opioid buprenorphine on pharyngeal swallow and respiratory drive in male and female rats. We also evaluated utility of serotonin 5-HT1A agonists (8-OH-DPAT and buspirone) to improve swallowing and breathing outcomes following buprenorphine administration. Experiments were performed on 44 freely breathing Sprague Dawley rats anesthetized with sodium pentobarbital...
August 22, 2023: bioRxiv
https://read.qxmd.com/read/37620290/incorporation-and-performance-verification-of-hepatic-portal-blood-flow-shunting-in-minimal-and-full-pbpk-models-of-liver-cirrhosis
#31
JOURNAL ARTICLE
Ben G Small, Oliver Hatley, Masoud Jamei, Iain Gardner, Trevor N Johnson
Patho-physiological changes in liver cirrhosis create portacaval shunts that allow blood flow to bypass the hepatic portal vein into the systemic circulation affecting drug pharmacokinetics (PK). The objectives of this work were to implement a Physiologically Based Pharmacokinetic (PBPK) framework describing shunted blood flows in virtual patients with differing degrees of liver cirrhosis; and to assess the minimal and full PBPK models performance using drugs with intermediate to high hepatic extraction. Single dose concentration-time profiles and PK parameters for oral Ibrutinib, midazolam, propranolol and buspirone were simulated in Healthy-Volunteer (HV) and subjects with cirrhosis (Child-Pugh severity score A, B or C)...
August 24, 2023: Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/37551844/implementing-a-stepwise-shivering-protocol-during-targeted-temperature-management
#32
JOURNAL ARTICLE
Czarina A Bock, Whitney G Medford, Emily Coughlin, Rahul Mhaskar, Katlynd M Sunjic
Background: Shivering is often encountered in patients undergoing targeted temperature management (TTM) after cardiac arrest. The most efficient, safe way to prevent shivering during TTM is not clearly defined. Objective: The purpose of this study was to evaluate the impact of shivering management using a stepwise shivering protocol on time to target temperature (TT), medication utilization and nursing confidence. Methods: Single-center, retrospective chart review of all post-cardiac arrest patients who underwent TTM between 2016 and 2021...
August 8, 2023: Journal of Pharmacy Practice
https://read.qxmd.com/read/37519173/time-dependent-effects-of-buspirone-versus-desipramine-on-the-5-choice-serial-reaction-time-task-in-rats-reared-in-social-isolation-implication-of-early-life-experience-and-motoric-impulsivity
#33
JOURNAL ARTICLE
Che-Se Tung, You-Wei Lin, Chen-Cheng Lin, Yia-Ping Liu
BACKGROUND: Early life social experience and the function of the central serotonin (5-Hydroxytryptophan, 5-HT) system are involved in development of behavioral impulsivity in which individuals act without forethought or before all necessary information is available. However, most of the evidence has been obtained from acute 5-HT manipulation, whereas, the present study aimed to investigate the effects of subchronic regimen targeting of 5-HT1A receptors on motoric waiting impulsivity in socially isolated rats...
June 27, 2023: Journal of Integrative Neuroscience
https://read.qxmd.com/read/37516898/drugs-for-anxiety-disorders
#34
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
August 7, 2023: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/37440017/repurposing-drugs-for-treatment-of-age-related-macular-degeneration
#35
JOURNAL ARTICLE
Sarah G Francisco, Sheldon Rowan
The need for new drugs to treat dry forms of age-related macular degeneration remains high. A promising approach is repurposing of FDA-approved medications to treat AMD. Databases containing medical and drug records allow for retroactive identification of drugs whose use correlates with reduced AMD diagnosis. This short review summarizes progress in several classes of drugs considered for repurposing: GPR-143 agonists (L-DOPA), anti-diabetic drugs (metformin, acarbose, empagliflozin, fenofibrate), mitochondrial activators (PU-91), and serotonin pathway drugs (fluoxetine, flibanserin, xaliproden, buspirone)...
2023: Advances in Experimental Medicine and Biology
https://read.qxmd.com/read/37428920/a-preparative-small-molecule-mimic-of-liver-cyp450-enzymes-in-the-aliphatic-c-h-oxidation-of-carbocyclic-n-heterocycles
#36
JOURNAL ARTICLE
Rachel K Chambers, Jacob D Weaver, Jinho Kim, Jason L Hoar, Shane W Krska, M Christina White
An emerging trend in small-molecule pharmaceuticals, generally composed of nitrogen heterocycles ( N -heterocycles), is the incorporation of aliphatic fragments. Derivatization of the aliphatic fragments to improve drug properties or identify metabolites often requires lengthy de novo syntheses. Cytochrome P450 (CYP450) enzymes are capable of direct site- and chemo-selective oxidation of a broad range of substrates but are not preparative. A chemoinformatic analysis underscored limited structural diversity of N -heterocyclic substrates oxidized using chemical methods relative to pharmaceutical chemical space...
July 18, 2023: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/37386328/the-serotonin-1a-5-ht-1a-receptor-as-a-pharmacological-target-in-depression
#37
REVIEW
Alexander L W Smith, Catherine J Harmer, Philip J Cowen, Susannah E Murphy
Clinical depression is a common, debilitating and heterogenous disorder. Existing treatments for depression are inadequate for a significant minority of patients and new approaches are urgently needed. A wealth of evidence implicates the serotonin 1A (5-HT1A ) receptor in the pathophysiology of depression. Stimulation of the 5-HT1A receptor is an existing therapeutic target for treating depression and anxiety, using drugs such as buspirone and tandospirone. However, activation of 5-HT1A raphe autoreceptors has also been suggested to be responsible for the delay in the therapeutic action of conventional antidepressants such as selective serotonin reuptake inhibitors (SSRIs)...
July 2023: CNS Drugs
https://read.qxmd.com/read/37378184/buspirone-in-autism-spectrum-disorder-a-systematic-review
#38
REVIEW
Nihit Gupta, Mayank Gupta, Raghu Gandhi
The aim of this systematic review is to appraise the current evidence on the efficacy and safety of buspirone in core symptoms of autism spectrum disorder (ASD), co-occurring anxiety, and other associated symptoms. Major medical literature databases were searched for randomized controlled trials (RCTs), open-label trials, and any other relevant studies or clinical trials reporting on pediatric (age < 18 years) patients with ASD treated with buspirone for any reason. A total of 310 abstracts were screened, and six clinical trials were selected for inclusion...
May 2023: Curēus
https://read.qxmd.com/read/37362512/diagnostic-overshadowing-in-high-functioning-autism-mirtazapine-buspirone-and-modified-cognitive-behavioral-therapy-cbt-as-treatment-options
#39
Nihit Gupta, Mayank Gupta
Diagnostic overshadowing (DO) is identified as a contributor to the missed diagnosis of individuals with an autism spectrum disorder (ASD). It has been used predominantly in the scientific literature and clinical settings to describe a phenomenon where a person's symptoms and behaviors are attributed solely to their primary diagnosis, rather than being recognized due to co-occurring conditions. DO is seen across many developmental disorders; however, females with autism may have a more difficult time getting diagnosed than males with autism because traditional diagnostic criteria for autism are often based on research that has primarily focused on males with autism...
May 2023: Curēus
https://read.qxmd.com/read/37341015/buspirone-attenuated-methotrexate-induced-hippocampal-toxicity-in-rats-by-regulating-nrf2-ho-1-ppar-%C3%AE-nf-%C3%AE%C2%BAb-nnos-and-ros-nlrp3-caspase-1-signaling-pathways
#40
JOURNAL ARTICLE
Hanan S Althagafy, Zeina W Sharawi, Ashwaq H Batawi, Hailah M Almohaimeed, Wafa S Al-Thubiani, Emad H M Hassanein, Amal Rateb
Methotrexate (MTX) is a chemotherapeutic agent widely used to treat a variety of tumors. Nonetheless, MTX-induced hippocampal neurotoxicity is a well-defined dose-limiting adverse effect that limits clinical utility. Proinflammatory cytokine production and oxidative stress are possible mechanisms for MTX-induced neurotoxicity. Buspirone (BSP), a partial agonist of the 5-HT1a receptor (5-HT1aR), has emerged as an anxiolytic drug. BSP has been shown to possess antioxidant and anti-inflammatory effects. The current study investigated BSP's potential anti-inflammatory and antioxidant effects in attenuating MTX-induced hippocampal toxicity...
June 21, 2023: Journal of Biochemical and Molecular Toxicology
keyword
keyword
11520
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.